Doxepin in the treatment of primary insomnia: A placebo-controlled, double-blind, polysomnographic study

Journal of Clinical Psychiatry

Volumn 62, Issue 6, 2001, Pages 453-463

  Hajak, G ^a   Rodenbeck, A ^a   Voderholzer, U ^a   Riemann, D ^a   Cohrs, S ^a   Hohagen, F ^a   Berger, M ^a   Ruther E ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOXEPIN; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; INSOMNIA; LEUKOPENIA; MALE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP PATTERN; THROMBOCYTOPENIA;

EID: 0034905737     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n0609     Document Type: Article

References (76)

1. Prevalence of sleep disturbances among young adults in three European countries
2. How a general population perceives its sleep and how this relates to the complaint of insomnia
3. Chronic sleep complaints: Results of a representative survey in Germany
4. Prevalence, burden, and treatment of insomnia in primary care
5. Form, frequency and burden of sleep problems in general health care: A report from the WHO Collaboration Study on Psychological Problems in General Health Care
6. Prevalence and persistence of sleep complaints in a rural older community sample: The MOVIES project
7. Prevalence and treatment of insomnia in general practice: A longitudinal study
8. Long-term follow up of chronic insomnia
9. Diagnosis and management of sleep problems in primary care: A challenge for public health
10. The direct economic cost of insomnia
11. Economic effects of insomnia
12. New epidemiologic findings about insomnia and its treatment
13. Prescription and intake patterns in long-term und ultra-long-term benzodiazepine treatment in primary care
14. Psychotropic medication consumption patterns in the UK general population
15. Insomnia and psychotropic drug consumption
16. Psychotropic medication and insomnia complaints in two epidemiological studies
17. Sleep complaints and hypnotic use by the elderly: Results of a representative survey in West Germany
18. Behavioral and pharmacological treatment therapies for late-life insomnia: A randomized controlled trial
19. Benzodiazepine problems
20. Anxiety or depression during withdrawal of hypnotic treatments
21. The benzodiazepine withdrawal syndrome
22. Dependence as a limiting factor in the clinical use of minor tranquilizers
23. Current benzodiazepine issues
24. Zopiclone: An update of its pharmacology, clinical efficacy and tolerability in the treatment of insomnia
25. Zopiclone: Is there any dependence and abuse potential?
26. Behavioral pharmacology of zolpidem relative to benzodiazepines: A review
27. Trimipramine: A challenge to current concepts on antidepressives
28. Nocturnal melatonin secretion and sleep after doxepin administration in chronic primary insomnia
29. Treatment of primary insomnia with trimipramine: An alternative to benzodiazepine hypnotics?
30. Ten-year trends in the pharmacological treatment of insomnia
31. Tricyclic antidepressants in the treatment of insomnia
32. A multi-center, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients
33. Effect of two antidepressant drugs on REM sleep and EMG activity during sleep
34. Sleep EEG and amitriptyline treatment in depressed inpatients
35. Rapid eye movement sleep and sleep continuity: Depression and antidepressants
36. Trimipramine, anxiety, depression and sleep
37. REM-suppressing effects of amitriptyline and amitriptyline-N-oxide after acute medication in healthy volunteers: Results of two uncontrolled pilot trials
38. Depression and sleep: The status of current research
39. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder
40. Effect of pharmacologic treatments on the sleep of depressed patients
41. Action of trimipramine on sleep and pituitary hormone secretion
42. Effects of mirtazapine on sleep architecture in patients with major depression: A pilot study
43. Effects of trazodone hydrochloride and imipramine on polysomnography in healthy subjects
44. Antidepressant withdrawal syndromes: Phenomenology and pathophysiology
45. Withdrawal phenomena associated with antidepressant and antipsychotic agents
46. Tricyclic antidepressant withdrawal syndrome
47. Antidepressant discontinuation: A review of the literature
48. Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: A double-blind randomized trial in major depression
49. Subjective hypnotic efficacy of trazodone and zolpidem in DSM-III-R primary insomnia
50. Paroxetine in the treatment of primary insomnia: Preliminary clinical and electroencephalogram sleep data
51. Trends in the pharmacologic treatment of insomnia
52. Outpatient use of prescription sedative-hypnotic drugs in the United States, 1970 through 1989
53. Clinical global impressions observer rating scale
54. Visual analogue scales to assess sleep quality
55. Empfehlungen zur durchführung und auswertung polysomnographischer ableitungen im diagnostischen schlaflabor
56. Rebound insomnia: A critical review
57. Rebound insomnia and newer hypnotics
58. Rebound insomnia: Its determinants and significance
59. Rebound insomnia in insomniac outpatients
60. Fischer Somatic Symptoms or Undesired Effects Check-List (FSUCL)
61. Use of the binomial theorem in interpreting results of multiple tests of significance
62. Changes during weeks in effects of tricyclic drugs on the human sleeping brain
63. A review of trimipramine: 30 Years of clinical use
64. Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression
65. Drug effects on REM sleep and on endogenous depression
66. Depression, circadian rhythms and trimipramine
67. Sleep onset insomnia, sleep maintaining insomnia and insomnia with early morning awakening: Temporal stability of subtypes in a longitudinal study on general practice attenders
68. Neural symptoms induced by tricyclic antidepressants: Phenomenology and pathophysiology
69. Antidepressant drugs: Disturbing and potentially dangerous adverse effects